Red & Blue Ventures is a privately owned, seed and early-stage venture capital fund that invests in technology companies with penn students, alumni, and faculty as key personnel. Media   and entertainment companies build identity-based brands that lead their space. It all starts with amazing original content that connects with people.

Red & Blue Ventures

Techstars Ventures (formerly Bullet Time Ventures) is the venture capital arm of Techstars. Bullet Time Ventures is a $150 million fund based in Boulder, Colorado.

Techstars Ventures

Alumni Ventures Group provides high-quality, diversified venture portfolios to individual investors who previously haven't had access to VC. It helps accredited alums from top entrepreneurial schools invest together in the ventures of fellow alums. The firm backs companies with an alumni connection and an institutional lead investor with expertise in the space. AVG also offers focused funds that allow any accredited investor access to a venture portfolio, diversified by type, sector, stage, and geography. Beth Obermiller, Michael Madden, and Mike Collins co-founded the firm in Manchester, New Hampshire in 2013.

Alumni Ventures

HearstLab is an early-stage venture fund focused on women-led startups innovating across the enterprise technology, data analytics, health, fintech, transportation and media spaces. To date, HearstLab has invested in over 56 companies at the Seed and Series A stages, with four successful exits. The firm often participates as a co-investor and in follow-on rounds.  HearstLab is a venture arm of the Hearst Corporation (''Hearst'') and provides one year of services in addition to cash investments. With access to Hearst's resources across 360+ businesses, HearstLab’s breadth of services includes providing assistance with commercial deals, privacy and security, legal services, marketing support and raising capital. Portfolio companies also benefit from the strategic guidance and resource support of HearstLab Scouts, women leaders across Hearst who share their networks and expertise. HearstLab has a full-time dedicated team assisting with UI/UX, DevOps engineering, data security, data science, brand storytelling, financial modeling and business development.

HearstLab

General Catalyst is a venture capital firm that provides early-stage and growth equity investments. The company provides ongoing momentum that accelerates ideas, careers, and companies toward standout success.

General Catalyst

Seae Ventures is a venture fund designed to maximize financial returns by investing in entrepreneurs who deliver superior value. It is dedicated to building and investing in early-stage healthcare technology and services companies

Seae Ventures

Frist Cressey Ventures is focused on accelerating the growth of high potential healthcare enterprises through value-added partnerships.  We invest in technology and service businesses with viable solutions that improve quality of care, system integration, patient outcomes, and population health and wellbeing.  We join like-minded entrepreneurs who share similar core values in their pursuit to improve healthcare.

Frist Cressey Ventures

MD Ally

MD Ally develops a telehealth emergency care platform to offer ease of access between public safety practitioners and providers. The company integrates telemedicine into the EMD process to triage callers, non-life-threatening concerns, virtual medical and behavioral healthcare professionals, in-network follow-up care, alternate transportation, and social services.

New York-based MD Ally develops a program that integrates into the dispatch systems used in 911 operations centers and reroutes non-emergency calls to licensed doctors for virtual care services, through a range of codes.

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

MD Ally scores $14M for emergency medical services telehealth platform

New York-based MD Ally develops a program that integrates into the dispatch systems used in 911 operations centers and reroutes non-emergency calls to licensed doctors for virtual care services, through a range of codes.Founded in 2018, MD Ally is free for any public service entity to use. The company plans to earn income from telehealth referrals and through insurance companies that intend to reduce the cost of emergency health services. As of April 2021, the company operated in New York, Florida, Louisiana, Arizona, and California. In Q1 2021, MD Ally experienced an over 19% YoY revenue growth to USD 4.3 million. In the same month, MD Ally concluded a seed funding round that brought the company’s total funds raised to USD 4.5 million. The funds will be used to expand R&amp;D, enhance its offering to include mental health services, and to double its employee count from the seven employees as of April 2021.As of August 2024, the company had partnered with major US cities and implemented national payor partnerships across Florida, Arizona, and California to serve over 5 million patients.

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

<div>

 911 virtual care solution provider MD Ally has secured USD 14 million in a Series A funding round. The investment was led by Frist Cressey Ventures and included contributions from General Catalyst, Techstars, Seae Ventures, Red &amp; Blue Ventures, and Alumni Ventures, bringing the company's total funding to USD 25 million.
 
 MD Ally plans to use the funding to broaden access to its virtual care solution. Additionally, the investment will allow for enhancements to the company's 911 and EMS-integrated technology, expansion of clinical services, and the establishment of additional downstream care coordination partnerships.
 
 The company's 911 virtual care program is designed to address non-emergency 911 calls, saving an average of USD 2,280 in healthcare costs per call. As of 2024, the company has formed alliances with major US cities and implemented national payor partnerships in Florida, Arizona, and California, thereby serving over 5 million patients.
 
</div>

MD Ally

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless